NFE2L2 and neoplasm: These findings underscore an integrated interplay between HIF-1 and NRF2 in the cellular response to hypoxia and in tumor progression, highlighting NRF2 as a candidate molecular target to control angiogenesis by imposing a blockade of HIF-1 signaling (Figure 3).